28:22

Next-generation AAV Vectors

27:06

Update on Phase I/II Clinical Trial for Ornithine Transcarbamylase (OTC) Deficiency Using AAV

1:01:33

Ask the Expert: Oncolytic Viral Therapies in the Treatment of Melanoma and Skin Cancers

16:31

Introduction to the immune system

26:12

Role of immune response modulation by BRAF inhibitor therapy

4:49

Oncolytic Viruses: A Treatment for Cancer?

23:42

Histoire et enjeux de l'immunothérapie - Wolf Hervé FRIDMAN

59:37

Around the World: Advanced Therapy Medicinal Production (ATMP) Research in South America